FDA.reportPublic FDA data

nirmatrelvir 150 MG ; ritonavir 100 MG Daily Dose Pack, Renal

RxCUI
2599542
RxNorm name
nirmatrelvir 150 MG ; ritonavir 100 MG Daily Dose Pack, Renal
Display name
nirmatrelvir 150 MG ; ritonavir 100 MG Daily Dose Pack, Renal
Full name
nirmatrelvir 150 MG ; ritonavir 100 MG Daily Dose Pack, Renal
Term type
PSN
Status
DailyMed mapping
Updated
2026-06-04 23:39:07

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
PaxlovidNIRMATRELVIR AND RITONAVIRPfizer Laboratories Div Pfizer Inc8a99d6d6-fd9e-45bb-b1bf-48c7f761232a2026-02-19Boxed warning, Warnings, Adverse reactionsExact identifier
rxcui: 2599542

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.

DailyMed RxNorm Mappings#

unique DailyMed labels mapped to this RxNorm concept page 1 of 1 · 1 matching rows.

Set ID, RxNorm mappings, Terms table
Set IDRxNorm mappingsTermsSPL versionLabelEffective
8a99d6d6-fd9e-45bb-b1bf-48c7f761232a{10 (nirmatrelvir 150 MG Oral Tablet) / 10 (ritonavir 100 MG Oral Tablet) } Pack [GPCK] · nirmatrelvir 150 MG ; ritonavir 100 MG Daily Dose Pack, Renal [PSN] · nirmatrelvir 150 MG Oral Tablet (10) / ritonavir 100 MG Oral Tablet (10) 150 MG /100 MG Dose Pack [SY]312These highlights do not include all the information needed to use PAXLOVID safely and effectively. See full prescribing information for PAXLOVID. PAXLOVID TM (nirmatrelvir tablets; ritonavir tablets), co-packaged for oral use Initial U.S. Approval: 202320260219